IFNA1 and neoplasm: To characterise the potential toxicity of local IFN-α gene therapy, different doses of AdCA-mIFN were injected into the AsPC-1 subcutaneous tumours, and the animals were killed 5 or 11 days later to evaluate serum enzyme values and histology of major organs.